How to talk to parents about HPV vaccines
Thursday, June 20, 2019
When is HPV a Problem?
Tuesday, June 18, 2019
Addressing Cervical Cancer Globally Requires Scaling Up HPV Vaccination, Expanding Screening, Treatment For Women
Tuesday, June 11, 2019
New York Times: We Have the Resources to Prevent Cervical Cancer. Do We Have the Will?
Mia Armstrong, 2019 graduate of Arizona State University and winner of Nicholas Kristof’s 2019 ‘win-a-trip’ contest
“…Although cervical cancer is the fourth most common cancer for women globally, claiming more lives than pregnancy and childbirth, we can save those lives if we can only summon the will. Health experts say that the battle against cervical cancer has two fronts. First, we need to scale up HPV vaccination to prevent cervical cancer. Second, we need to expand screening and treatment for women now in danger. These are relatively affordable, straightforward interventions that can make a big difference in a lot of lives. … But here’s the problem: Only around 25 percent of 10-year-old girls live in countries that have introduced the HPV vaccine, according to WHO estimates from October 2018. … [C]hallenges [to vaccine implementation] are not insurmountable. … If vaccines are the sword in the battle of eliminating cervical cancer, screening initiatives are the shield. … While the Pap test is effective if conducted regularly, it requires a medical structure often lacking in poor countries. So public health experts have experimented with two other screening tests, one that uses vinegar to identify cancer and precancerous lesions, and another that uses DNA to identify HPV infections that could cause cervical cancer. They’re both useful…” (6/10).Continue to Article
Human trials of HPV cancer vaccine expected to begin by year's end
Wednesday, May 22, 2019
Researchers have advanced a cancer vaccine to human trials as part of pioneering research aimed at treating incurable HPV cancers of the head, neck, throat and tongue.
The research combines a newly developed Human Papillomavirus (HPV) vaccine with immunotherapy and is being spearheaded by Professor Ian Frazer and Brisbane's Princess Alexandra Hospital's Professor Sandro Porceddu.
"We are seeing an unprecedented rise in the incidence of HPV-associated oropharyngeal cancer (OPC) with the USA reporting a 225 per cent increase since the 1980s," Professor Porceddu said.
Rwanda has fought to stamp out cervical cancer – they might just be the first country to do it
Tuesday, May 21, 2019
As Rwanda gears up for a new round of vaccinations later this year, the immunologist responsible for the vaccine that has saved so many women’s lives believes the world cannot be complacent. “You can’t be happy until everyone has been vaccinated,” Frazer says.
5 Things You Didn’t Know About HPV—The Most Common STD
Monday, May 6, 2019
Vaccine reduces HPV prevalence among teen girls by 86% in 10 years
Monday, May 6, 2019
HPV-Oral Cancer Link Spotlights Health Disparities Among Men
Wednesday, April 24, 2019
Dating after 40? The millions who are should get the HPV vaccine
Tuesday, April 16, 2019
Anyone under 45 who plans to be sexually active in the future should not miss this window of opportunity and should take action before reaching the age cutoff. Talk to your doctor or pharmacist about getting the HPV vaccine. Three shots, a copay and some shoulder soreness are a small price to pay to be inoculated from cancer-causing viruses.
The HPV vaccine is important for preteens and teenagers. What about older women?
Saturday, April 13, 2019
‘Is Gardasil 9 right for me?” my patient asked during a recent office visit.
She is 45, recently divorced from her husband of 20 years and crafting her online dating profile. She’s also wondering whether she is a candidate for the vaccine that protects against nine strains of the human papilloma virus (HPV) — a virus that causes most cervical, oral and anal cancer.